We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+4.99%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+632.23%
AUM
$110B
AUM Growth
+$11.3B
(+11%)
Cap. Flow
+$8.89B
Cap. Flow
% of AUM
8.09%
Top 10 Holdings %
Top 10 Hldgs %
35.27%
Holding
3,643
New
809
Increased
972
Reduced
1,047
Closed
744
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$3.35B |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$2.85B |
| 3 |
Eli Lilly
LLY
|
+$999M |
| 4 |
Coca-Cola
KO
|
+$685M |
| 5 |
Broadcom
AVGO
|
+$616M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.38B |
| 2 |
Apple
AAPL
|
+$1.12B |
| 3 |
Netflix
NFLX
|
+$678M |
| 4 |
Boston Scientific
BSX
|
+$671M |
| 5 |
Cencora
COR
|
+$627M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.19% |
| 2 | Consumer Discretionary | 12.77% |
| 3 | Healthcare | 10.45% |
| 4 | Financials | 7.74% |
| 5 | Communication Services | 5.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2376
Phreesia
PHR
$758M
| $344K | ﹤0.01% |
20,317
-116,531
| -85% | -$2.4M |
|
|
ARTV
2377
Artiva Biotherapeutics
ARTV
$576M
| $341K | ﹤0.01% |
+79,559
| New | +$300K |
|
2378
Agilysys
AGYS
$3.01B
| $340K | ﹤0.01% |
2,864
-5,536
| -66% | -$666K |
|
2379
TScan Therapeutics
TCRX
$50.8M
| $339K | ﹤0.01% |
339,240
+292,610
| +628% | +$424K |
|
2380
Biohaven
BHVN
$2.18B
| $339K | ﹤0.01% |
+30,027
| New | +$372K |
|
2381
Alignment Healthcare
ALHC
$2.74B
| $338K | ﹤0.01% |
17,131
-13,864
| -45% | -$249K |
|
2382
PUT
Upstart Holdings
UPST
$2.91B
| $337K | ﹤0.01% |
7,700
+2,200
| +40% | +$101K |
|
2383
RXO
RXO
$3.54B
| $336K | ﹤0.01% |
26,559
-154,890
| -85% | -$2.28M |
|
2384
Everest Group
EG
$14B
| $335K | ﹤0.01% |
986
+160
| +19% | +$52.8K |
|
2385
Zentalis Pharmaceuticals
ZNTL
$295M
| $335K | ﹤0.01% |
+247,788
| New | +$361K |
|
|
CHCT
2386
Community Healthcare Trust
CHCT
$432M
| $334K | ﹤0.01% |
+20,356
| New | +$304K |
|
2387
PagerDuty
PD
$915M
| $333K | ﹤0.01% |
25,383
-26,010
| -51% | -$379K |
|
2388
Clorox
CLX
$13.1B
| $333K | ﹤0.01% |
3,300
-45,799
| -93% | -$4.97M |
|
2389
International Seaways
INSW
$4.41B
| $332K | ﹤0.01% |
+6,832
| New | +$338K |
|
2390
CALL
State Street SPDR S&P Metals & Mining ETF
XME
$4.56B
| $332K | ﹤0.01% |
3,200
+100
| +3% | +$9.88K |
|
2391
Eve Holding
EVEX
$993M
| $332K | ﹤0.01% |
83,092
-347,486
| -81% | -$1.53M |
|
2392
Vipshop
VIPS
$7.2B
| $330K | ﹤0.01% |
18,650
-89,291
| -83% | -$1.72M |
|
2393
iShares US Regional Banks ETF
IAT
$682M
| $330K | ﹤0.01% |
+5,980
| New | +$311K |
|
2394
PUT
HCA Healthcare
HCA
$89.1B
| $327K | ﹤0.01% |
+700
| New | +$325K |
|
2395
CF Bankshares
CFBK
$231M
| $326K | ﹤0.01% |
13,054
-11,136
| -46% | -$266K |
|
|
FFIC
2396
DELISTED
Flushing Financial
FFIC
| $324K | ﹤0.01% |
+21,368
| New | +$324K |
|
2397
Burford Capital
BUR
$953M
| $324K | ﹤0.01% |
36,333
-279,878
| -89% | -$2.74M |
|
|
GREK
2398
Global X MSCI Greece ETF
GREK
$330M
| $323K | ﹤0.01% |
+4,902
| New | +$319K |
|
2399
Vanguard Russell 1000 Value ETF
VONV
$22B
| $322K | ﹤0.01% |
+3,494
| New | +$317K |
|
2400
Sunstone Hotel Investors
SHO
$1.98B
| $322K | ﹤0.01% |
+36,043
| New | +$331K |
|
Similar funds
Marshall Wace's Q4 2025 Portfolio in Review
As of Q4 2025, Marshall Wace held 3,643 positions worth $110B, up 11% from $98.6B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Marshall Wace deployed $8.89B of net new capital in Q4 2025, opening 809 new positions and adding to 972 existing holdings. Its largest new stake was Vanguard S&P 500 ETF: 4,580,704 shares worth $2.87B.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 20% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Microsoft, an estimated $1.38B trimmed.
- Marshall Wace's largest Q4 2025 buy was Vanguard S&P 500 ETF: 4,580,704 shares worth $2.87B.
- Marshall Wace added most to iShares Core S&P 500 ETF in Q4 2025, an estimated $3.35B increase.
- Marshall Wace's biggest Q4 2025 reduction was Microsoft, cutting an estimated $1.38B.
- Marshall Wace fully exited Ares Management in Q4 2025, selling an estimated $146M.
- Marshall Wace's ten largest holdings make up 35% of its $110B portfolio in Q4 2025.
- Marshall Wace opened 809 new positions and closed 744 in Q4 2025.
- Marshall Wace's portfolio value rose 11% quarter-over-quarter to $110B.
Based on Marshall Wace's 13F filing for Q4 2025, filed 13 Feb 2026.